Abstract
Background and Aims: Among the HDL atheroprotective function, the most known is the ability of promoting cholesterol efflux from macrophages, termed cholesterol efflux capacity (CEC) and considered a better predictor of cardiovascular disease (CVD) than HDL levels. Moreover, the capacity of serum to load macrophages with cholesterol (cholesterol loading capacity, CLC) represents an index of serum pro-atherogenic potential. As transgender individuals are exposed to lifelong exogenous hormone therapy, we investigated whether HDL-CEC, HDL subclasses and serum CLC are affected by hormone treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
